Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kapvay as add-on to psychostimulants in ADHD
NCT00641329Phase 3Completed
- Sponsor
- Addrenex Pharmaceuticals
- Start
- Feb 2008
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clonidine in attention deficit hyperactivity disorder (ADHD), sponsored by Addrenex Pharmaceuticals. Started Feb 2008; status: completed.
02
Drugs
clonidine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00641329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00641329.